Selected research
Industry Research
Amoxicillin and Clavulanate Potassium Industry Research Report 2026
Market perspective
The global Amoxicillin and Clavulanate Potassium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amoxicillin and Clavulanate Potassium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amoxicillin and Clavulanate Potassium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amoxicillin and Clavulanate Potassium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amoxicillin and Clavulanate Potassium include GSK, Health Biotech, Bright Future Pharmaceutical Laboratories, Guangzhou Baiyunshan Pharmaceutical, China National Pharmaceutical Group Corp, North China Pharmaceutical Group, Pfizer, United Laboratories Internat and Lunan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amoxicillin and Clavulanate Potassium market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amoxicillin and Clavulanate Potassium Market by Company
GSK
Health Biotech
Bright Future Pharmaceutical Laboratories
Guangzhou Baiyunshan Pharmaceutical
China National Pharmaceutical Group Corp
North China Pharmaceutical Group
Pfizer
United Laboratories Internat
Lunan Pharmaceutical Group
Sandoz
Simcere Pharmaceutical
Amoxicillin and Clavulanate Potassium Segment by Type
Tablet
Oral Liquid
Amoxicillin and Clavulanate Potassium Segment by Application
Hospital
Pharmacy
Amoxicillin and Clavulanate Potassium Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amoxicillin and Clavulanate Potassium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amoxicillin and Clavulanate Potassium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amoxicillin and Clavulanate Potassium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amoxicillin and Clavulanate Potassium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amoxicillin and Clavulanate Potassium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amoxicillin and Clavulanate Potassium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Liquid
Applications
- Hospital
- Pharmacy
Companies covered
- GSK
- Health Biotech
- Bright Future Pharmaceutical Laboratories
- Guangzhou Baiyunshan Pharmaceutical
- China National Pharmaceutical Group Corp
- North China Pharmaceutical Group
- Pfizer
- United Laboratories Internat
- Lunan Pharmaceutical Group
- Sandoz
- Simcere Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amoxicillin and Clavulanate Potassium Market Size (2021-2032)
- 2.2.2 Global Amoxicillin and Clavulanate Potassium Sales (2021-2032)
- 2.2.3 Global Amoxicillin and Clavulanate Potassium Market Average Price (2021-2032)
- 2.3 Amoxicillin and Clavulanate Potassium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Oral Liquid
- 2.4 Amoxicillin and Clavulanate Potassium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amoxicillin and Clavulanate Potassium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amoxicillin and Clavulanate Potassium Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Amoxicillin and Clavulanate Potassium Revenue of Manufacturers (2021-2026)
- 3.4 Global Amoxicillin and Clavulanate Potassium Average Price by Manufacturers (2021-2026)
- 3.5 Global Amoxicillin and Clavulanate Potassium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amoxicillin and Clavulanate Potassium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amoxicillin and Clavulanate Potassium, Product Type & Application
- 3.8 Global Manufacturers of Amoxicillin and Clavulanate Potassium, Established Date
- 3.9 Global Amoxicillin and Clavulanate Potassium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Health Biotech
- 4.2.1 Health Biotech Company Information
- 4.2.2 Health Biotech Business Overview
- 4.2.3 Health Biotech Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Health Biotech Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.2.5 Health Biotech Recent Developments
- 4.3 Bright Future Pharmaceutical Laboratories
- 4.3.1 Bright Future Pharmaceutical Laboratories Company Information
- 4.3.2 Bright Future Pharmaceutical Laboratories Business Overview
- 4.3.3 Bright Future Pharmaceutical Laboratories Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bright Future Pharmaceutical Laboratories Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.3.5 Bright Future Pharmaceutical Laboratories Recent Developments
- 4.4 Guangzhou Baiyunshan Pharmaceutical
- 4.4.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 4.4.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 4.4.3 Guangzhou Baiyunshan Pharmaceutical Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guangzhou Baiyunshan Pharmaceutical Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.4.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 4.5 China National Pharmaceutical Group Corp
- 4.5.1 China National Pharmaceutical Group Corp Company Information
- 4.5.2 China National Pharmaceutical Group Corp Business Overview
- 4.5.3 China National Pharmaceutical Group Corp Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 China National Pharmaceutical Group Corp Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.5.5 China National Pharmaceutical Group Corp Recent Developments
- 4.6 North China Pharmaceutical Group
- 4.6.1 North China Pharmaceutical Group Company Information
- 4.6.2 North China Pharmaceutical Group Business Overview
- 4.6.3 North China Pharmaceutical Group Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 North China Pharmaceutical Group Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.6.5 North China Pharmaceutical Group Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 United Laboratories Internat
- 4.8.1 United Laboratories Internat Company Information
- 4.8.2 United Laboratories Internat Business Overview
- 4.8.3 United Laboratories Internat Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 United Laboratories Internat Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.8.5 United Laboratories Internat Recent Developments
- 4.9 Lunan Pharmaceutical Group
- 4.9.1 Lunan Pharmaceutical Group Company Information
- 4.9.2 Lunan Pharmaceutical Group Business Overview
- 4.9.3 Lunan Pharmaceutical Group Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lunan Pharmaceutical Group Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.9.5 Lunan Pharmaceutical Group Recent Developments
- 4.10 Sandoz
- 4.10.1 Sandoz Company Information
- 4.10.2 Sandoz Business Overview
- 4.10.3 Sandoz Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sandoz Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.10.5 Sandoz Recent Developments
- 4.11 Simcere Pharmaceutical
- 4.11.1 Simcere Pharmaceutical Company Information
- 4.11.2 Simcere Pharmaceutical Business Overview
- 4.11.3 Simcere Pharmaceutical Amoxicillin and Clavulanate Potassium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Simcere Pharmaceutical Amoxicillin and Clavulanate Potassium Product Portfolio
- 4.11.5 Simcere Pharmaceutical Recent Developments
5 Global Amoxicillin and Clavulanate Potassium Market Scenario by Region
- 5.1 Global Amoxicillin and Clavulanate Potassium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amoxicillin and Clavulanate Potassium Sales by Region: 2021-2032
- 5.2.1 Global Amoxicillin and Clavulanate Potassium Sales by Region: 2021-2026
- 5.2.2 Global Amoxicillin and Clavulanate Potassium Sales by Region: 2027-2032
- 5.3 Global Amoxicillin and Clavulanate Potassium Revenue by Region: 2021-2032
- 5.3.1 Global Amoxicillin and Clavulanate Potassium Revenue by Region: 2021-2026
- 5.3.2 Global Amoxicillin and Clavulanate Potassium Revenue by Region: 2027-2032
- 5.4 North America Amoxicillin and Clavulanate Potassium Market Facts & Figures by Country
- 5.4.1 North America Amoxicillin and Clavulanate Potassium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amoxicillin and Clavulanate Potassium Sales by Country (2021-2032)
- 5.4.3 North America Amoxicillin and Clavulanate Potassium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Amoxicillin and Clavulanate Potassium Market Facts & Figures by Country
- 5.5.1 Europe Amoxicillin and Clavulanate Potassium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amoxicillin and Clavulanate Potassium Sales by Country (2021-2032)
- 5.5.3 Europe Amoxicillin and Clavulanate Potassium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Amoxicillin and Clavulanate Potassium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amoxicillin and Clavulanate Potassium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amoxicillin and Clavulanate Potassium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amoxicillin and Clavulanate Potassium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amoxicillin and Clavulanate Potassium Market Facts & Figures by Country
- 5.7.1 South America Amoxicillin and Clavulanate Potassium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amoxicillin and Clavulanate Potassium Sales by Country (2021-2032)
- 5.7.3 South America Amoxicillin and Clavulanate Potassium Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Amoxicillin and Clavulanate Potassium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amoxicillin and Clavulanate Potassium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amoxicillin and Clavulanate Potassium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amoxicillin and Clavulanate Potassium Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Amoxicillin and Clavulanate Potassium Sales by Type (2021-2032)
- 6.1.1 Global Amoxicillin and Clavulanate Potassium Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Amoxicillin and Clavulanate Potassium Sales Market Share by Type (2021-2032)
- 6.2 Global Amoxicillin and Clavulanate Potassium Revenue by Type (2021-2032)
- 6.2.1 Global Amoxicillin and Clavulanate Potassium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amoxicillin and Clavulanate Potassium Revenue Market Share by Type (2021-2032)
- 6.3 Global Amoxicillin and Clavulanate Potassium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amoxicillin and Clavulanate Potassium Sales by Application (2021-2032)
- 7.1.1 Global Amoxicillin and Clavulanate Potassium Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Amoxicillin and Clavulanate Potassium Sales Market Share by Application (2021-2032)
- 7.2 Global Amoxicillin and Clavulanate Potassium Revenue by Application (2021-2032)
- 7.2.1 Global Amoxicillin and Clavulanate Potassium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amoxicillin and Clavulanate Potassium Revenue Market Share by Application (2021-2032)
- 7.3 Global Amoxicillin and Clavulanate Potassium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amoxicillin and Clavulanate Potassium Value Chain Analysis
- 8.1.1 Amoxicillin and Clavulanate Potassium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amoxicillin and Clavulanate Potassium Production Mode & Process
- 8.2 Amoxicillin and Clavulanate Potassium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amoxicillin and Clavulanate Potassium Distributors
- 8.2.3 Amoxicillin and Clavulanate Potassium Customers
9 Global Amoxicillin and Clavulanate Potassium Analyzing Market Dynamics
- 9.1 Amoxicillin and Clavulanate Potassium Industry Trends
- 9.2 Amoxicillin and Clavulanate Potassium Industry Drivers
- 9.3 Amoxicillin and Clavulanate Potassium Industry Opportunities and Challenges
- 9.4 Amoxicillin and Clavulanate Potassium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst